NIH-funded research R01 grant

Antibodies that block peanut allergic reactions

Official title: Neutralizing antibodies in food allergy

Funded at Massachusetts General Hospital · NIH-11225103 · Data updated 2026-11-12

This project looks at whether certain protective antibodies help children and adults with peanut allergy stay protected after oral immunotherapy.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionMassachusetts General Hospital
NIH-funded
Lab location1 site (Boston, United States)
Project startNovember 20, 2020
Project endJanuary 31, 2031
Funding year2026
Award (this year)$594,000
NIH project number2R01AI155630-06
Project IDNIH-11225103 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are children or adults with IgE-mediated peanut allergy, especially those who have undergone or plan to undergo oral immunotherapy and can provide blood samples.

Less likely to help

People without IgE-mediated peanut allergy or whose allergies are to foods other than peanut are unlikely to receive direct benefit from this project.

What this research studies

If you have peanut allergy, researchers are studying antibodies made after oral immunotherapy that might keep you protected even if you stop regular peanut exposure. They collect blood and B cells from people who had lasting protection and from those who lost protection, then clone and analyze the allergen-specific antibodies. The team uses lab allergy tests and structural methods to see how these antibodies block the allergy-causing IgE from binding the peanut protein Ara h 2, and they test combinations of antibodies in lab and animal models. Their goal is to understand why only some people make these neutralizing antibodies and how that could guide new, longer-lasting treatments.

Why it matters

Potential benefit: If successful, this work could lead to antibody-based treatments or ways to improve oral immunotherapy so more people get lasting protection from peanut allergy.

How similar studies have gone: Oral immunotherapy commonly desensitizes patients and prior work has linked increased IgG4 to treatment, but identifying specific neutralizing antibodies and defining their structures is a newer and promising approach.

Where this research is happening

  • Massachusetts General Hospital
    Boston, United States
    Active

Researchers

  • Principal investigator: Patil, Sarita U — Massachusetts General Hospital
  • Study coordinator: Patil, Sarita U

Related research

Other NIH-funded projects on the same topics.

  • New Horizons in preventing and treating food allergy

    A Johns Hopkins-led effort aims to advance how we prevent and treat food allergies across all ages by coordinating high-quality studies and developing better therapies.

    NIH research Johns Hopkins University · Baltimore, United States · NIH-11600582

  • New Horizons in Food Allergy Prevention and Treatment

    A large, multi-site program at Johns Hopkins aims to advance prevention and treatment of food allergies across all ages.

    NIH research Johns Hopkins University · Baltimore, United States · NIH-11580809

  • Food allergy outcomes by race/ethnicity from infancy through adolescence

    This study follows children with food allergies over time to understand how race and ethnicity relate to allergy management, outcomes, and quality of life.

    NIH research Northwestern University · Chicago, United States · NIH-11579222

  • Gut-brain links in food allergy responses

    A research grant is exploring how signals between the gut and brain drive dangerous reactions to foods, with the goal of helping people with food allergies.

    NIH research Yale University · New Haven, United States · NIH-11551492

  • Targeting gut microbes to restore food-tolerance in adults

    Aims to understand how gut bacteria and the lining of the gut interact to keep people with food allergies tolerant to what they eat.

    NIH research Boston Children's Hospital · Boston, United States · NIH-11551491

  • Environment and early-life exposures shaping food allergy in children

    This grant looks at how a child’s first year and their home environment may influence whether they develop food allergies, focusing on indoor exposures and microbes.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11450430

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.